Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
The underdiagnosis of sleep disorders in patients with multiple sclerosis.
Multiple sclerosis: clinical features and MRI findings in Northern China.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
Fingolimod Therapy and Macular Hemorrhage.
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Schwann cells in therapy of spinal cord injuries.
[A case of neuromyelitis optica presenting ileus as a neurologic finding].
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Perceptions of health status in multiple sclerosis patients and their doctors.
Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females.
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.
The common marmoset as a novel animal model system for biomedical and neuroscience research applications.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial.
The role of microglial activation in disease progression.
Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis.
18F-FDG PET/CT in Tumefactive Multiple Sclerosis.
Pages
« first
‹ previous
…
233
234
235
236
237
238
239
240
241
…
next ›
last »